On 2 July, ABL Bio announced a capital raise worth 140 billion won which involves 5.77 million new shares (10.7% of outstanding shares post capital raise) at 24,229 won per share.
What is covered in the Full Insight:
Introduction
Capital Raise Details
Use of Proceeds
Financial Performance
Company Background
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.